Novel pyridinium surfactants for efficient, nontoxic in vitro gene delivery.
about
Developing a programmed restriction endonuclease for highly specific DNA cleavagePore forming polyalkylpyridinium salts from marine sponges versus synthetic lipofection systems: distinct tools for intracellular delivery of cDNA and siRNACationic lipid-formulated DNA vaccine against hepatitis B virus: immunogenicity of MIDGE-Th1 vectors encoding small and large surface antigen in comparison to a licensed protein vaccineReconstitution of membrane proteins into giant unilamellar vesicles via peptide-induced fusion.Lipoplex formation under equilibrium conditions reveals a three-step mechanism.Spatial organization of bacteriorhodopsin in model membranes. Light-induced mobility changes.Polymorphism of pyridinium amphiphiles for gene delivery: influence of ionic strength, helper lipid content, and plasmid DNA complexation.Novel gemini cationic lipids with carbamate groups for gene delivery.Lipid and polymeric carrier-mediated nucleic acid delivery.Towards mitochondrial gene therapy: DQAsomes as a strategy.Cationic lipid-mediated transfection in vitro and in vivo (review).Raft-mediated trafficking of apical resident proteins occurs in both direct and transcytotic pathways in polarized hepatic cells: role of distinct lipid microdomainsStrategies to improve non-viral vectors--potential applications in clinical transplantation.Structural and formulation factors influencing pyridinium lipid-based gene transfer.Detergent induction of HEK 293A cell membrane permeability measured under quiescent and superfusion conditions using whole cell patch clampAction and reaction: the biological response to siRNA and its delivery vehicles.Heterocyclic cationic gemini surfactants: a comparative overview of their synthesis, self-assembling, physicochemical, and biological properties.Cationic antimicrobial polymers and their assemblies.Efficient and synergetic DNA delivery with pyridinium amphiphiles-gold nanoparticle composite systems having different packing parameters.Cationic lipophosphoramidates with two different lipid chains: synthesis and evaluation as gene carriers.Modulation of pyridinium cationic lipid-DNA complex properties by pyridinium gemini surfactants and its impact on lipoplex transfection properties.Efficient cationic lipid-mediated delivery of antisense oligonucleotides into eukaryotic cells: down-regulation of the corticotropin-releasing factor receptor.Structure-transfection activity relationships in a series of novel cationic lipids with heterocyclic head-groups.Overcoming nonviral gene delivery barriers: perspective and future.Surface-directed assembly of cell-laden microgelsAdvanced materials for co-delivery of drugs and genes in cancer therapy.Lipid chain geometry of C14 glycerol-based lipids: effect on lipoplex structure and transfection.Persistent downregulation of the pancarcinoma-associated epithelial cell adhesion molecule via active intranuclear methylation.Phase behavior of cationic amphiphiles and their mixtures with helper lipid influences lipoplex shape, DNA translocation, and transfection efficiency.Common co-lipids, in synergy, impart high gene transfer properties to transfection-incompetent cationic lipids.A nonviral carrier for targeted gene delivery to tumor cells.Serum as a modulator of lipoplex-mediated gene transfection: dependence of amphiphile, cell type and complex stability.A Family of Photolabile Nitroveratryl-Based Surfactants That Self-Assemble into Photodegradable Supramolecular Structures.Efficient gene delivery of primary human cells using peptide linked polyethylenimine polymer hybrid.Nano-sized calcium phosphate particles for periodontal gene therapy.(Glyco)sphingolipids are sorted in sub-apical compartments in HepG2 cells: a role for non-Golgi-related intracellular sites in the polarized distribution of (glyco)sphingolipids.Molecular shape of the cationic lipid controls the structure of cationic lipid/dioleylphosphatidylethanolamine-DNA complexes and the efficiency of gene delivery.Lipoplex-mediated transfection of mammalian cells occurs through the cholesterol-dependent clathrin-mediated pathway of endocytosis.Identification of types of membrane injuries and cell death using whole cell-based proton-sensitive field-effect transistor systems.A novel vector system for gene transfer into the cornea using a partially dried plasmid expressing 18 basic fibroblast growth factor-synthetic amphiphile INTeraction-18 (SAINT-18) complex.
P2860
Q24812943-62E8E514-F273-4C83-A9C8-2EAACF59972CQ25255567-DCA6955A-819B-4A00-B194-8D7E02364B89Q28656316-A5C409B1-0A67-4BD5-8AB6-2850AA2E9E74Q30328563-B19287B2-EADE-429A-A92F-74AA53A39405Q30503643-4708695A-145B-414A-AF5C-70DA570F14CFQ30841642-E44C3361-A320-4019-A4D7-820CC28289F0Q30979053-AA782DF9-B751-4A8A-ADD8-826A1C653AACQ33910095-E807DA96-E3EB-4BA8-B74B-57EAE48249B7Q34155795-BFD8A82B-BEF6-4488-9B78-7A7920086F00Q34265156-27180758-4243-4E0A-B87E-3BA0468C12CAQ34313548-F9717417-74CB-47F2-A740-68333B6D65C3Q34764402-15CE5D23-7940-4EF2-B145-3A04EEFBB69FQ36481006-CAA710BD-8474-470B-85D2-D192BD227356Q37190052-F7B359CC-B3E6-4C89-90CF-AF28A0C8AC9AQ37697368-17DFFD78-C27D-4E06-B16D-42BAA47FF8EAQ37976576-CBE6CD60-8F59-47ED-B74A-FDA9F2C24D80Q38036135-D9240F9C-20CA-41AB-B13E-AAD8A51349C1Q38105908-71C9395A-CB11-47F4-BE4C-E155FA7A7CB1Q38820608-FB924907-06A4-4046-B72B-5A00522D25E5Q39032601-792C633E-8770-4924-9871-EC761B58F561Q39038484-8DFDBB76-EDA9-4AC8-8086-B195A41F647BQ39085570-C3E2CC0B-C7C2-4058-8805-907FE2976A85Q39093073-50C3842B-5777-49DB-B43C-33F7838253D6Q39339350-513A2082-47B5-4C95-AD2B-6059BD8E5468Q39442586-CD09CD19-29D4-46C3-8380-B92010399B34Q39513734-80295DE8-1B75-4696-94B7-83ED498A37B1Q39634716-8A11A492-F75F-4DA8-A5B3-36530612A27CQ39993789-DA4B223B-43D5-405C-9365-76E3728A1B47Q40215343-8323BC4D-6843-4454-A7A0-FE1E5BCC6C8BQ40458449-CED21BE4-8A09-4D43-AF85-7A965FCCBBD8Q40603994-22E0C2D9-8CCD-4EAB-876B-87269586234BQ40825417-13AF33D5-AF81-417C-AC65-DBD6C306C6FCQ42048343-BEDBDE1F-DC22-4C3F-92FD-BEC8A329DAF4Q42729751-0C4F6A5B-51EE-4088-94F4-311C6B0ADFB3Q42798305-59F813D3-CD8E-4C4B-8FB4-8D93930E5D69Q42855134-288397C1-D921-46E4-AE27-D68FA70A4C1DQ43754776-DF318C45-E584-4BA2-9F1C-095964F4273FQ43903254-591C5148-66F4-4515-8E08-3A2DA824FA75Q46318031-311E7AA4-BF3C-48A9-A5A6-1ACA5FFAF7DBQ46318099-2BB01E03-F816-47DD-9832-3DA9B00790E2
P2860
Novel pyridinium surfactants for efficient, nontoxic in vitro gene delivery.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Novel pyridinium surfactants for efficient, nontoxic in vitro gene delivery.
@ast
Novel pyridinium surfactants for efficient, nontoxic in vitro gene delivery.
@en
type
label
Novel pyridinium surfactants for efficient, nontoxic in vitro gene delivery.
@ast
Novel pyridinium surfactants for efficient, nontoxic in vitro gene delivery.
@en
prefLabel
Novel pyridinium surfactants for efficient, nontoxic in vitro gene delivery.
@ast
Novel pyridinium surfactants for efficient, nontoxic in vitro gene delivery.
@en
P2093
P2860
P356
P1476
Novel pyridinium surfactants for efficient, nontoxic in vitro gene delivery.
@en
P2093
A A Meekel
A Wagenaar
D Hoekstra
I van der Woude
J B Engberts
M B ter Beest
M H Ruiters
P2860
P304
P356
10.1073/PNAS.94.4.1160
P407
P577
1997-02-01T00:00:00Z